Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Addict Biol. 2012 Jun 28;18(6):10.1111/j.1369-1600.2012.00461.x. doi: 10.1111/j.1369-1600.2012.00461.x

Figure 1.

Figure 1

Peak (mean ± SEM) subjective ratings of ‘Alert’ and marijuana and alcohol craving during experimenter-administered marijuana (MJ) smoking (6.2% THC) and marijuana withdrawal as a function of quetiapine dose. Participants rated each effect on a 100 mm line (0 mm = ‘not at all’; 100 mm = ‘extremely’). Data obtained from participants endorsing alcohol intake at least 1/week are portrayed for alcohol craving (N = 7). Under placebo conditions, significant differences between active marijuana administration and marijuana withdrawal are indicated by a bracket. A line above two adjacent bars indicates a significant difference between placebo and quetiapine conditions (* = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001).